Francois Brisebois
Stock Analyst at LifeSci Capital
(3.42)
# 2,284
Out of 4,598 analysts
377
Total ratings
38.9%
Success rate
3.3%
Average return
Main Sectors:
Stocks Rated by Francois Brisebois
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRD Opus Genetics | Reiterated: Buy | $10 | $3.63 | +175.48% | 12 | Aug 3, 2026 | |
| DYN Dyne Therapeutics | Reiterated: Buy | $44 | $25.93 | +69.69% | 31 | Jul 31, 2026 | |
| MPLT MapLight Therapeutics | Reiterated: Buy | $45 → $37 | $12.82 | +188.61% | 5 | Jul 27, 2026 | |
| LRMR Larimar Therapeutics | Maintained: Buy | $25 | $4.11 | +509.01% | 8 | Jul 21, 2026 | |
| PRAX Praxis Precision Medicines | Reiterated: Buy | $719 | $311.34 | +130.94% | 30 | Jul 21, 2026 | |
| DFTX Definium Therapeutics | Reiterated: Buy | $63 | $42.84 | +47.06% | 28 | Jul 15, 2026 | |
| TARS Tarsus Pharmaceuticals | Reiterated: Buy | $95 | $61.15 | +55.36% | 29 | Jul 13, 2026 | |
| CMPS COMPASS Pathways | Maintained: Buy | $24 | $11.60 | +106.90% | 16 | Jul 11, 2026 | |
| AQST Aquestive Therapeutics | Reiterated: Buy | $9 | $3.75 | +140.00% | 17 | Jun 25, 2026 | |
| SVRA Savara | Reiterated: Buy | $10 | $5.44 | +83.82% | 31 | Jun 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $2.47 | +102.43% | 14 | May 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.7449 | - | 27 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $61 | $38.19 | n/a | 15 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $18.34 | n/a | 27 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $80 | $23.96 | n/a | 5 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $6.63 | n/a | 2 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $1.53 | n/a | 4 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $30 | $7.36 | n/a | 3 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $6.36 | n/a | 14 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.98 | n/a | 1 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.91 | n/a | 11 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 | $14.18 | n/a | 7 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $6.53 | n/a | 12 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $90 → $20 | $1.15 | n/a | 3 | Aug 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $60 | $2.24 | n/a | 4 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $2.03 | n/a | 4 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 → $100 | $0.0001 | n/a | 2 | Sep 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $18 | $0.447 | n/a | 1 | Jul 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $92.18 | n/a | 1 | May 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $18 | $0.5755 | n/a | 1 | Feb 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8.5 → $4 | $0.97 | n/a | 2 | Sep 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $68 → $72 | $7.62 | n/a | 2 | Sep 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 → $15 | $0.0001 | n/a | 2 | Sep 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.5 → $1 | $1.03 | n/a | 2 | Jul 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $50 | $1.50 | n/a | 1 | Jun 27, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $0.7852 | n/a | 1 | Feb 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $2.04 | n/a | 1 | May 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $210 | $0.0716 | n/a | 1 | Feb 13, 2018 |
Opus Genetics
Aug 3, 2026
Reiterated: Buy
Price Target: $10
Current: $3.63
Upside: +175.48%
Dyne Therapeutics
Jul 31, 2026
Reiterated: Buy
Price Target: $44
Current: $25.93
Upside: +69.69%
MapLight Therapeutics
Jul 27, 2026
Reiterated: Buy
Price Target: $45 → $37
Current: $12.82
Upside: +188.61%
Larimar Therapeutics
Jul 21, 2026
Maintained: Buy
Price Target: $25
Current: $4.11
Upside: +509.01%
Praxis Precision Medicines
Jul 21, 2026
Reiterated: Buy
Price Target: $719
Current: $311.34
Upside: +130.94%
Definium Therapeutics
Jul 15, 2026
Reiterated: Buy
Price Target: $63
Current: $42.84
Upside: +47.06%
Tarsus Pharmaceuticals
Jul 13, 2026
Reiterated: Buy
Price Target: $95
Current: $61.15
Upside: +55.36%
COMPASS Pathways
Jul 11, 2026
Maintained: Buy
Price Target: $24
Current: $11.60
Upside: +106.90%
Aquestive Therapeutics
Jun 25, 2026
Reiterated: Buy
Price Target: $9
Current: $3.75
Upside: +140.00%
Savara
Jun 9, 2026
Reiterated: Buy
Price Target: $10
Current: $5.44
Upside: +83.82%
May 16, 2026
Maintained: Buy
Price Target: $5
Current: $2.47
Upside: +102.43%
Oct 24, 2025
Rated: Hold
Price Target: n/a
Current: $0.7449
Upside: -
Apr 8, 2025
Reiterated: Buy
Price Target: $61
Current: $38.19
Upside: n/a
Apr 4, 2025
Reiterated: Buy
Price Target: $65
Current: $18.34
Upside: n/a
Mar 28, 2025
Maintained: Buy
Price Target: $4 → $80
Current: $23.96
Upside: n/a
Mar 20, 2025
Reiterated: Buy
Price Target: $16
Current: $6.63
Upside: n/a
Mar 3, 2025
Reiterated: Buy
Price Target: $12
Current: $1.53
Upside: n/a
Feb 28, 2025
Reiterated: Buy
Price Target: $28 → $30
Current: $7.36
Upside: n/a
Jan 8, 2025
Reiterated: Buy
Price Target: $11
Current: $6.36
Upside: n/a
Aug 26, 2024
Rated: Hold
Price Target: n/a
Current: $8.98
Upside: n/a
Aug 26, 2024
Rated: Hold
Price Target: n/a
Current: $8.91
Upside: n/a
Jul 29, 2024
Maintained: Buy
Price Target: $36
Current: $14.18
Upside: n/a
Jul 1, 2024
Reiterated: Buy
Price Target: $6
Current: $6.53
Upside: n/a
Aug 17, 2023
Maintained: Buy
Price Target: $90 → $20
Current: $1.15
Upside: n/a
Apr 3, 2023
Maintained: Buy
Price Target: $8 → $60
Current: $2.24
Upside: n/a
Mar 23, 2023
Maintained: Buy
Price Target: $5
Current: $2.03
Upside: n/a
Sep 27, 2022
Maintained: Buy
Price Target: $80 → $100
Current: $0.0001
Upside: n/a
Jul 18, 2022
Initiated Coverage: Buy
Price Target: $18
Current: $0.447
Upside: n/a
May 11, 2020
Initiated Coverage: Buy
Price Target: n/a
Current: $92.18
Upside: n/a
Feb 4, 2020
Initiated Coverage: Buy
Price Target: $18
Current: $0.5755
Upside: n/a
Sep 10, 2019
Maintained: Buy
Price Target: $8.5 → $4
Current: $0.97
Upside: n/a
Sep 4, 2019
Maintained: Buy
Price Target: $68 → $72
Current: $7.62
Upside: n/a
Sep 4, 2019
Maintained: Buy
Price Target: $23 → $15
Current: $0.0001
Upside: n/a
Jul 29, 2019
Maintained: Hold
Price Target: $1.5 → $1
Current: $1.03
Upside: n/a
Jun 27, 2019
Upgraded: Buy
Price Target: $50
Current: $1.50
Upside: n/a
Feb 20, 2019
Maintained: Buy
Price Target: $11
Current: $0.7852
Upside: n/a
May 24, 2018
Reiterated: Buy
Price Target: $26
Current: $2.04
Upside: n/a
Feb 13, 2018
Maintained: Buy
Price Target: $210
Current: $0.0716
Upside: n/a